Evidence map›Paper›PMID 18235503›Full record

ArticleNature2008

Structure and mechanism of the M2 proton channel of influenza A virus.

Jason R Schnell, James J Chou

Abstract read
In one paragraph

Article in Nature, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 461 papers.

0numbers the graph read from it
0cells of the map it votes in
461citing papers in PubMed
60.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

461 citing papers in PubMed, 1,064 citations in OpenAlex.

  1. Review
  2. Article
  3. Influenza.Nature reviews. Disease primers · 2026
    Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Ion-Channel-Targeting Drugs for Chikungunya Virus.Molecules (Basel, Switzerland) · 2025
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

401 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jason R SchnellDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, USA.
James J Chou
Harvard University · US

Funding

Structural basis for influenza amantadine-resistanceR01AI067438 · NIAID · HARVARD MEDICAL SCHOOL · PI CHOU, JAMES JEIWEN · 2006 to 2010
$1.6M
NIAID NIH HHS R01 AI067438
6 · The paper itself

Abstract

The integral membrane protein M2 of influenza virus forms pH-gated proton channels in the viral lipid envelope. The low pH of an endosome activates the M2 channel before haemagglutinin-mediated fusion. Conductance of protons acidifies the viral interior and thereby facilitates dissociation of the matrix protein from the viral nucleoproteins--a required process for unpacking of the viral genome. In addition to its role in release of viral nucleoproteins, M2 in the trans-Golgi network (TGN) membrane prevents premature conformational rearrangement of newly synthesized haemagglutinin during transport to the cell surface by equilibrating the pH of the TGN with that of the host cell cytoplasm. Inhibiting the proton conductance of M2 using the anti-viral drug amantadine or rimantadine inhibits viral replication. Here we present the structure of the tetrameric M2 channel in complex with rimantadine, determined by NMR. In the closed state, four tightly packed transmembrane helices define a narrow channel, in which a 'tryptophan gate' is locked by intermolecular interactions with aspartic acid. A carboxy-terminal, amphipathic helix oriented nearly perpendicular to the transmembrane helix forms an inward-facing base. Lowering the pH destabilizes the transmembrane helical packing and unlocks the gate, admitting water to conduct protons, whereas the C-terminal base remains intact, preventing dissociation of the tetramer. Rimantadine binds at four equivalent sites near the gate on the lipid-facing side of the channel and stabilizes the closed conformation of the pore. Drug-resistance mutations are predicted to counter the effect of drug binding by either increasing the hydrophilicity of the pore or weakening helix-helix packing, thus facilitating channel opening.

Indexed as

Aspartic AcidDisulfidesDrug Resistance, ViralHydrogen BondingHydrophobic and Hydrophilic InteractionsInfluenza A virusIon Channel GatingModels, MolecularNuclear Magnetic Resonance, BiomolecularProtein Structure, QuaternaryProtein Structure, SecondaryProtonsRimantadineStructure-Activity RelationshipTryptophanViral Matrix ProteinsAspartic AcidDisulfidesM2 protein, Influenza A virusProtonsRimantadineTryptophanViral Matrix ProteinsViroporin ProteinsWater

Identifiers

PMID18235503
PMCPMC3108054
OpenAlexW2037831301

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.